Article Versions Notes

Maksymowicz J, Palko-Łabuz A, Sobieszczańska B, Chmielarz M, Ferens-Sieczkowska M, Skonieczna M, Wikiera A, Wesołowska O, Środa-Pomianek K. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals. 2022; 15(6):732. https://doi.org/10.3390/ph15060732

Maksymowicz, Jerzy, Anna Palko-Łabuz, Beata Sobieszczańska, Mateusz Chmielarz, Mirosława Ferens-Sieczkowska, Magdalena Skonieczna, Agnieszka Wikiera, Olga Wesołowska, and Kamila Środa-Pomianek. 2022. "The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan" Pharmaceuticals 15, no. 6: 732. https://doi.org/10.3390/ph15060732

Maksymowicz, J., Palko-Łabuz, A., Sobieszczańska, B., Chmielarz, M., Ferens-Sieczkowska, M., Skonieczna, M., Wikiera, A., Wesołowska, O., & Środa-Pomianek, K. (2022). The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals, 15(6), 732. https://doi.org/10.3390/ph15060732